Top Clinical Trials companies in France by Dividend Yield

This ranking features the top 30 Clinical Trials companies in France ranked by Dividend Yield, averaging a Dividend Yield of NA, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in France has the highest Dividend Yield ?

The Clinical Trials company in France with the highest Dividend Yield is Sanofi (Paris Stock Exchange: SAN.PA) at 4.07%.

Which Clinical Trials company in France has the lowest Dividend Yield ?

The Clinical Trials company in France with the lowest Dividend Yield is genOway SA (Paris Stock Exchange: ALGEN.PA) at None.

What are the top 10 Clinical Trials companies in France by Dividend Yield ?

The top 10 Clinical Trials companies in France by Dividend Yield are Sanofi, Guerbet SA, Ipsen S.A., bioMérieux S.A., AB Science S.A., ABIVAX SA, Aelis Farma SA, Crossject SA, Cellectis S.A. and Eurobio Scientific SA.

What are the bottom 10 Clinical Trials companies in France by Dividend Yield ?

The bottom 10 Clinical Trials companies in France by Dividend Yield are genOway SA, Adocia SA, Affluent Medical SA, Advicenne S.A., EDAP TMS S.A., Biosynex SA, ABIONYX Pharma SA, Aelis Farma SA, ABIVAX SA and Median Technologies SA.